1 - 10 out of 26Page size: 10
  1. 2023

  2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

    Verburgh, M. L., van Pul, L., Grobben, M., Boyd, A., Wit, F. W. N. M., van Nuenen, A. C., van Dort, K. A., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., Schim van der Loeff, M. F., van der Valk, M., van Gils, M. J., Kootstra, N. A. & Reiss, P., 11 May 2023, (E-pub ahead of print) In: Microbiology spectrum. p. e0115523

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in cellulo

    Alvarez, G., van Pul, L., Robert, X., Artía, Z., van Nuenen, A. C., Long, M., Sierra, N., Porcal, W., Kootstra, N. A. & Guillon, C., 1 Dec 2022, In: BMC pharmacology & toxicology. 23, 1, 43.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Older people with well-controlled HIV have similar antibody and higher T-cell responses after vaccination against SARS-CoV-2 compared to demographically and lifestyle-comparable people without HIV

    Verburgh, M., van Pul, L., Grobben, M., Boyd, A., Wit, F., van Nuenen, A., van Dort, K., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., van der Loeff, M. S., van der Valk, M., van Gils, M., Kootstra, N. & Reiss, P., 1 Oct 2022, In: Journal of the International AIDS Society. 25, 6, SI, p. 7-9 3 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs

    van der Donk, L. E. H., Eder, J., van Hamme, J. L., Brouwer, P. J. M., Brinkkemper, M., van Nuenen, A. C., van Gils, M. J., Sanders, R. W., Kootstra, N. A., Bermejo-Jambrina, M. & Geijtenbeek, T. B. H., Apr 2022, In: European journal of immunology. 52, 4, p. 646-655 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

    van Gils, M. J., van Willigen, H. D. G., Wynberg, E., Han, A. X., van der Straten, K., Burger, J. A., Poniman, M., Oomen, M., Tejjani, K., Bouhuijs, J. H., Verveen, A., Lebbink, R., Dijkstra, M., Appelman, B., Lavell, A. H. A., Caniels, T. G., Bontjer, I., van Vught, L. A., Vlaar, A. P. J., Sikkens, J. J., & 32 othersBomers, M. K., Russell, C. A., Kootstra, N. A., Sanders, R. W., Prins, M., de Bree, G. J., de Jong, M. D., RECoVERED Study Group, Agard, I., Ayal, J., Boyd, A., Cavdar, F., Craanen, M., Davidovich, U., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., Hartman, J., Koedoot, N., van den Aardweg, J., Boeser-Nunnink, B., Moll van Charante, E., van Dort, K., Hidad, S., Jurriaans, S., Knoop, H., Lok, A., Maurer, I., Nieuwkerk, P., van Nuenen, A. & Matser, A., 18 Jan 2022, In: Cell Reports Medicine. 3, 1, 100486.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2021

  9. Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans

    Bermejo-Jambrina, M., Eder, J., Kaptein, T. M., van Hamme, J. L., Helgers, L. C., Vlaming, K. E., Brouwer, P. J. M., van Nuenen, A. C., Spaargaren, M., de Bree, G. J., Nijmeijer, B. M., Kootstra, N. A., van Gils, M. J., Sanders, R. W. & Geijtenbeek, T. B. H., 18 Oct 2021, In: EMBO journal. 40, 20, e106765.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication

    Kruize, Z., Cobos Jiménez, V., Martinez, F. O., di Vincenzo, R., van Dort, K. A., van Nuenen, A. C., Booiman, T. & Kootstra, N. A., 1 Oct 2021, In: Virology. 562, p. 9-18 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction

    Kruize, Z., van Nuenen, A. C., van Wijk, S. W., Girigorie, A. F., van Dort, K. A., Booiman, T. & Kootstra, N. A., 6 Mar 2021, In: Viruses. 13, 3, 423.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. 2017

  13. Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing

    van der Ree, M. H., Stelma, F., Willemse, S. B., Brown, A., Swadling, L., van der Valk, M., Sinnige, M. J., van Nuenen, A. C., de Vree, J. M. L., Klenerman, P., Barnes, E., Kootstra, N. A. & Reesink, H. W., 2017, In: Antiviral research. 146, p. 139-145

    Research output: Contribution to journal › Article › Academic › peer-review

  14. Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients

    van der Ree, M. H., Jansen, L., Kruize, Z., van Nuenen, A. C., van Dort, K. A., Takkenberg, R. B., Reesink, H. W. & Kootstra, N. A., 2017, In: Journal of infectious diseases. 215, 9, p. 1421-1429

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 Next

ID: 98776